As of 2025-10-15, the Intrinsic Value of Themis Medicare Ltd (THEMISMED.NS) is 23.69 INR. This THEMISMED.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 124.60 INR, the upside of Themis Medicare Ltd is -81.00%.
The range of the Intrinsic Value is 17.41 - 36.13 INR
Based on its market price of 124.60 INR and our intrinsic valuation, Themis Medicare Ltd (THEMISMED.NS) is overvalued by 81.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 17.41 - 36.13 | 23.69 | -81.0% |
| DCF (Growth 10y) | 22.87 - 46.91 | 31.00 | -75.1% |
| DCF (EBITDA 5y) | 48.05 - 97.57 | 64.93 | -47.9% |
| DCF (EBITDA 10y) | 41.25 - 94.54 | 59.11 | -52.6% |
| Fair Value | -14.06 - -14.06 | -14.06 | -111.28% |
| P/E | (17.35) - 62.50 | 19.93 | -84.0% |
| EV/EBITDA | 8.67 - 90.53 | 36.59 | -70.6% |
| EPV | 20.39 - 33.67 | 27.03 | -78.3% |
| DDM - Stable | (4.11) - (10.06) | (7.09) | -105.7% |
| DDM - Multi | 18.41 - 37.76 | 25.03 | -79.9% |
| Market Cap (mil) | 11,468.18 |
| Beta | 2.05 |
| Outstanding shares (mil) | 92.04 |
| Enterprise Value (mil) | 12,169.70 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.80% |
| Cost of Debt | 16.26% |
| WACC | 16.54% |